BFM
RMD icon

Boothbay Fund Management’s ResMed RMD Stock Holding History

Boothbay Fund Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,444
Closed -$248K – 1883
2023
Q4 		$248K Sell
1,444
-119
-8% -$18.3K 0.01% 1264
2023
Q3 		$231K Sell
1,563
-504
-24% -$91.1K 0.01% 1378
2023
Q2 		$452K Sell
2,067
-295
-12% -$65.7K 0.01% 1154
2023
Q1 		$517K Sell
2,362
-326
-12% -$70.7K 0.01% 1242
2022
Q4 		$559K Sell
2,688
-2,918
-52% -$641K 0.01% 1131
2022
Q3 		$1.22M Buy
5,606
+2,667
+91% +$607K 0.03% 782
2022
Q2 		$616K Sell
2,939
-53
-2% -$11.3K 0.02% 1072
2022
Q1 		$726K Sell
2,992
-2,344
-44% -$567K 0.02% 1097
2021
Q4 		$1.39M Buy
+5,336
New +$1.38M 0.03% 619
2021
Q3 		– Sell
-3,080
Closed -$759K – 2144
2021
Q2 		$759K Sell
3,080
-17,885
-85% -$3.76M 0.02% 816
2021
Q1 		$4.07M Buy
+20,965
New +$4.2M 0.15% 136

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Boothbay Fund Management's RMD Position: Q1 2024 in Review

Boothbay Fund Management sold out of ResMed (RMD) in Q1 2024, closing a stake of 1,444 shares — an estimated $248K sold.

Boothbay Fund Management first reported a position in RMD in Q1 2021 and held it in 11 quarters. The position peaked at $4.07M in Q1 2021. 718 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

  • Boothbay Fund Management reported no remaining ResMed position as of Q1 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 1,444 ResMed shares in Q1 2024, an estimated $248K.
  • Boothbay Fund Management first reported a position in ResMed in Q1 2021 and held it in 11 quarters.
  • Boothbay Fund Management's ResMed position peaked at $4.07M in Q1 2021.
  • 718 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Boothbay Fund Management's 13F filing for Q1 2024, filed 15 May 2024.